Pharmacies and Pharmaceutical Firms - Rules in Progress

Rules in Progress

Pharmacy related email inbox: PharmacyRules@doh.wa.gov

Significant legislative rule-making process

CR-101 – Statement of Inquiry (Rules under development/examination – stakeholder workshops)

CR-102 – Notice of Proposed Rule Making (Approved rule language, official public comment period and notice of rules hearing.)

CR-103 – Rule making Order (Notice of adopted rules or notice of emergency rule adoption)

CR-105 – Expedited Rule Making due to the limited scope of a CR-105, there is no public hearing. A person may object to the use of the expedited rule-making process within 45 days after the notice of proposed rulemaking is filed.

Inquiry Phase (CR-101)

Utilization of Pharmacy Ancillary Personnel: WSR 24-18-032 (PDF)
Pharmaceutical Manufacturers and Wholesalers: WSR 26-11-028 (PDF)
Updates to Nonnarcotic Stimulant Drugs: WSR 26-13-013 (PDF)
Scheduling Synthetic Benzodiazepines: WSR 26-15-126 (PDF)
Change of Pharmacy Ownership: WSR 26-16-006 (PDF)
Accreditation of Schools or Colleges of Pharmacy: WSR 26-15-108 (PDF)
Mercury Compounds Designation: WSR 26-17-065 (PDF)
Collaborative Drug Therapy Agreement Submission Requirement: WSR 26-18-004 (PDF)
Pharmacy Technicians and Training Programs: WSR 26-18-021 (PDF)
Pharmacy Assistant Registration: WSR 26-19-063 (PDF)

Rule Proposed - Pending public rules hearing (CR-102)

Animal Euthanasia Training Program Guidelines: WSR 26-19-065 (PDF)
Tamper-Resistant Prescription Pads and Paper: WSR 26-19-069 (PDF)
Accessible Prescription Labeling Refinement (Supplemental): WSR 26-19-097 (PDF)
Pharmacy Personnel Examinations and Procedures: WSR 26-22-025 (PDF)

Recently Adopted Rules (CR-103)

Prescription Transfer Requirement: WSR 24-24-024 (PDF)
Incorporation by Reference of the DSCSA: WSR 25-19-024 (PDF)
Permanent Facility Closure Requirements: WSR 25-07-097 (PDF)
Accessible Labeling Standards: WSR 25-04-003 (PDF)
Uniform Facility Enforcement Framework: WSR 25-17-089 (PDF)
Inspection Requirements for Modifications or Remodels: WSR 25-21-016 (PDF)
Suspicious Orders and Zero Reports: WSR 25-21-014 (PDF)
Disciplinary Action Reporting Time Frames: WSR 26-04-018 (PDF)
Expanding Types of Medication Assistance: WSR 26-08-065 (PDF)
Incorporations by Reference Update: WSR 26-13-027 (PDF)
Clarifying Ancillary Utilization Plans: WSR 26-15-078 (PDF)
Mobile Opioid Treatment Program (OTP) Units: WSR 26-17-010 (PDF)
Scheduling Synthetic Benzodiazepines (CR-103E): WSR 26-19-064 (PDF)

Expedited Rule - (CR-105)

None at this time.